Innovation driven by people.

Jade Chao, MPH JD

CO-FOUNDER / COO, GENERAL COUNCIL

Jade is Co-Founder, Chief Operating Officer, and General Counsel. She has a chemistry / biostatistics background and is well versed in the area of human iPSC biology. She is admitted to practice before the United States Patent & Trademark Office, and a member of the California Bar Association. She serves as the head of several education and community nonprofit boards advocating for women in leadership. Jade enjoys gardening, calligraphy, and swimming.

Amit Parikh, MBA

CFO / OUTFORCE, LLP

Joseph Wu, MD, PhD

CO-FOUNDER

Joseph C. Wu, MD, PhD is a Co-Founder Greenstone Biosciences. A board-certified cardiologist, he is Director of the Stanford Cardiovascular Institute and the Simon H. Stertzer, MD, Professor of Medicine and Radiology. Dr. Wu received his M.D. from Yale and his Ph.D. in molecular pharmacology from UCLA. Over the past 15 years, his lab has studied extensively on the application of iPSCs for disease modeling, drug discovery, and regenerative medicine. In these fields, he has published over 450 peer-reviewed articles with an H-index of 113 and recognition as top 1% of highly cited researchers in the world for past 4 years (2018, 2019, 2020, 2021). He has received several prestigious awards and recognitions from the NIH and AHA. Dr. Wu is a member of the National Academy of Medicine. He is also President-Elect of the American Heart Association for the 2022-2023 term.

Lip-Bu Tan

CHAIR, BOARD OF DIRECTORS

Paul Pang, PhD

SENIOR SCIENTIST

Paul is a biomedical scientist with over a decade of research experience in disease modeling and translational medicine. Paul received his PhD in Integrative Molecular & Biomedical Sciences from Baylor College of Medicine and completed his postdoctoral training at Stanford University in the lab of Dr. Joseph Wu. He has been a prolific contributor to scientific literature and has received numerous awards and prestigious fellowships including the Ruth L. Kirschstein F31 and F32 NRSA Fellowships by the National Institutes of Health. In addition to his scientific interests, Paul enjoys playing volleyball, exploring new places, and writing short stories.

Robin Shivnaraine, PhD

SENIOR SCIENTIST

Rabindra (Robin) received his PhD from the Department of Pharmaceutical Sciences at the University of Toronto and his graduate work focused on the mechanism of allosteric modulators at G-protein coupled receptors (GPCRs). After, he joined Stanford University as a post-doctoral and Dean’s Fellow of the School of Medicine where he worked with Professor Brian Kobilka to under the how conformational changes in GPCRs determine their function. For this work, he was co-mentored by Professor Steven Chu to develop biophysical methods to assess GPCR function and this work was awarded with an interdisciplinary fellowship from the Stanford Neurosciences Institute. Robin enjoys playing tennis and biking and can be seen occasionally enjoying the beautiful biking trails in California.

Chun Liu, PhD

SENIOR SCIENTIST

Chun completed his postdoctoral training at Stanford University School of Medicine’s Cardiovascular Institute after receiving his PhD in Stem Cell Biology from Peking University.

He currently serves as an Instructor at Stanford University focusing on the development of novel technologies for stem cell therapy, disease modeling, and drug screening using cardiovascular cells. Chun primarily employs human induced pluripotent stem cells (iPSCs) as a model system and state-of-the-art CRISPR screening tools to develop novel therapeutic targets for cardiovascular disorders at Greenstone.

Siyeon Rhee, PhD

SENIOR SCIENTIST

Siyeon received his Ph.D. from the University of Massachusetts, Amherst, where he studied developmental biology, specifically liver and pancreas organogenesis. He then pursued Postdoctoral training at Stanford University where he focused on cardiovascular development.

Currently he is working at the Stanford Cardiovascular Institute to understand the role of endothelial cells in congenital heart diseases using patient iPSC lines. Siyeon also works as a semi-professional photographer for academic and wedding events and has been contributing to K-BioX association, a non-profit organization for Korean life scientists and students, as a representative committee member.

Angela Zhang

RESEARCH ASSOCIATE

Angela graduated from Harvard College in 2016, majoring in Biomedical Engineering. She then matriculated to Stanford Medical School, where she is currently a MD/PhD student in the Joseph C. Wu lab pursuing a PhD in Genetics and PhD minor in CS. Her research interests include applying deep learning methods to stem cell technology to advance drug screening and disease modeling. A Bay Area native, Angela enjoys hiking and eating her way around California.

Celine Lai

RESEARCH ASSOCIATE

Celine received her Bachelor’s degree in biochemistry from the University of California, Los Angeles.

After, she worked with CRISPR-edited cancer lines before transitioning to the cardiovascular field at Dr. Joseph Wu’s lab at the Stanford Cardiovascular Institute. Away from the lab, she enjoys traveling and trying out different desserts.

Chelsea Lee, MS

RESEARCH ASSOCIATE

Chelsea is a Research Associate at Greenstone Biosciences, Inc. She earned her B.S. in Applied Molecular Biology & Biotechnology at the University of Delaware and a M.S. in Stem Cell Biology and Regenerative Medicine at USC. While working in Joseph C. Wu’s Lab at Stanford University, she co-authored several scientific publications in top scientific journals on patient stem cells with cardiomyopathies. Chelsea develops targeted- therapeutics so that one day patients will be treated with their own personalized medicine. Chelsea enjoys exploring the San Francisco Bay Area, swimming, and drawing.

Chris Yan

SENIOR RESEARCH ASSOCIATE

Chris graduated from Reed College in Portland, OR with a Bachelor’s degree in Biochemistry and Molecular Biology. He then worked at the Stanford Cardiovascular Institute modeling genetic and cardiovascular diseases.

With a broad experience spanning the biotechnology sector, he has a deep interest in how we can provide better therapies at scale and reform the arduous process of drug discovery. A San Francisco Bay Area native, he can be found playing ultimate frisbee or trying new foods to eat.